Document is current
Any future updates will be listed below
-
Authors
St-Onge, Juliette https://orcid.org/0009-0006-3123-4872
Brodeur, Magaly https://orcid.org/0000-0003-3856-1877
Légaré, Andrée-Anne https://orcid.org/0000-0001-9276-1306
Deschamps, Amélie https://orcid.org/0009-0001-4789-334X
Auger, Anne-Marie https://orcid.org/0000-0002-8499-7666
Muñoz Gómez, Natalia https://orcid.org/0009-0005-4373-9993
Hudon, Catherine https://orcid.org/0000-0001-6140-9916
Jutras-Aswad, Didier https://orcid.org/0000-0002-8474-508X
Håkansson, Anders https://orcid.org/0000-0002-5800-8975
Parent, Virginie
Morvannou, Adèle https://orcid.org/0000-0001-6333-8816
-
Funding
Funding for this research was provided by:
Fonds de recherche du Québec (324497)
- License Information
-
More Information
Article History
Received: 25 November 2025
Accepted: 19 March 2026
First Online: 24 March 2026
Declarations
:
: This study was conducted in accordance with the principled outlined by the Declaration of Helsinki. The research protocol was approved by the ethics committee of the Centre intégré universitaire de santé et de services sociaux (CIUSSS) de l’Estrie—Centre hospitalier universitaire de Sherbrooke (CHUS) on July 19th, 2023 (2024-5139-CyberD-Cannabis). The data were anonymized, and all the participants provided free and informed written consent.
: Not applicable.
: Dr. Jutras-Aswad has received study materials (oral cannabidiol and inhaled cannabidiol and THC) from Cardiol Therapeutics and Exka for publicly funded clinical trials examining the behavioral, cognitive and biological effects of cannabinoids. Other authors declare that they have no competing interests.
